Pharmacy/Admixture Technician
US Oncology Network-wide Career Opportunities | |
United States, Tennessee, Nashville | |
2004 Hayes Street (Show on map) | |
Dec 30, 2025 | |
|
Overview
SCRI Oncology Partners, located in Nashville, Tenn., is a dedicated cancer treatment center led by globally recognized oncologists with disease expertise in cancer care and clinical research. This center offers patients state-of-the art personalized cancer care and opportunities to participate in clinical trials with innovative treatments. The practice conducts clinical trials through their affiliation with Sarah Cannon Research Institute (SCRI), a global leader in oncology research that has been offering and managing clinical trials in the community for over 30 years. Since its inception, SCRI has contributed to pivotal research that has helped advance the majority of new cancer therapies approved by the FDA today. SCOPE:
Responsibilities ESSENTIAL DUTIES AND RESPONSIBILITIES:
Qualifications MINIMUM QUALIFICATIONS:
PHYSICAL REQUIREMENTS: The physical demands described here are representative of those that must be met by an employee to successfully perform the essential functions of this job. Reasonable accommodation may be made to enable individuals with disabilities to perform the essential functions. Physical demands of this job typically require full range of body motion including manual and finger dexterity and eye-hand coordination and the ability to read and note appropriate measurements. Requires sitting/standing for extensive periods of time. Occasionally lifts and carries items weighing up to 40 lbs. Requires corrected vision and hearing to normal range. WORK ENVIRONMENT: The work environment characteristics described here are representative of those an employee encounters while performing the essential functions of this job. Reasonable accommodation may be made to enable individuals with disabilities to perform the essential functions. While performing the duties of this job, the employee is regularly exposed to direct contact with patients with potential exposure to toxic substances, medicinal preparations, and chemotherapeutic agents. | |
Dec 30, 2025